A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
about
PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.Podocalyxin as a Prognostic Marker in Gastric CancerExpression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research.
P2860
A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
@ast
A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
@en
type
label
A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
@ast
A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
@en
prefLabel
A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
@ast
A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
@en
P2093
P2860
P50
P356
P1433
P1476
A comparative study of two PODXL antibodies in 840 colorectal cancer patients
@en
P2093
Caj Haglund
Christian Fermér
Olle Nilsson
Tuomas Kaprio
P2860
P2888
P356
10.1186/1471-2407-14-494
P407
P577
2014-07-08T00:00:00Z
P5875
P6179
1022062015